Previous 10 | Next 10 |
CLEVELAND , April 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Zach Stassen has been named Chief Financial Officer, effective May 18, 2020 . Mr. Stassen will report directly to Scott Drake , President and Chief Executive Officer. M...
CLEVELAND , April 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2020 . First Quarter 2020 Highlights: Total revenue of $14.3 million , primarily from three revenue units including one sys...
ViewRay Inc. (NASDAQ: VRAY) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are dropping coverage of ViewRay Inc. due to a reallocation of resources. Our final rating is Buy, and our final price target is $7.00. Our former es...
Adverum Biotechnologies (NASDAQ: ADVM ) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs. More news on: Adverum Biotechnologies, Inc., Alector, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
CLEVELAND , April 16, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020 . Ms. Johnson brings a wealth of health care and medical technology knowledge, as well as broad expe...
CLEVELAND , April 9, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, April 30, 2020 at 4:30 p.m. ET / 1:30 ...
ViewRay (NASDAQ: VRAY ) announces a strategic collaboration with VieCure, an artificial intelligence (AI) informatics company. The collaboration is designed to drive personalized care and treatment to patients by educating oncology practices on both companies' precision oncology solut...
CLEVELAND , April 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today a strategic collaboration with VieCure, an artificial intelligence (AI) informatics company with a leading point-of-care clinical decision support platform and a comprehensive electronic medical record ...
Calithera Biosciences (NASDAQ: CALA ) initiated with Buy rating and $6 (34% upside) price target at Jefferies. More news on: Calithera Biosciences, Inc., bluebird bio, Inc., Charles River Laboratories International, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
CLEVELAND , March 19, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Enloe Medical Center – an independent, nonprofit hospital in Chico , California– has entered into a master agreement for the purchase of a MRIdian MRI-guided radiation ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...